Master of Biotechnology (Biomedical) (MBiotech(Biomed))

Program Code

MBIB

Academic Year

2024

Special Notes

These Program Rules should be read in conjunction with the University's policies (http://www.adelaide.edu.au/policies).

Overview

This program explores the full spectrum of the biotechnology sector, spanning the discovery, research and development phases. Students will be exposed to a range of technology platforms, and develop highly competitive laboratory and project management skills. In addition, students will examine many of the contemporary issues related to biotechnology, including compliance and regulation, commercialisation and risk management strategies.

The application of biomedical research is a key focus of the curriculum, particularly as it relates to career opportunities in the Asia Pacific region.

The Master of Biotechnology (Biomedical) is an AQF Level 9 Masters qualification with a standard full-time duration of 2 years.  Students who have received a GPA of > 6.0 for the first year will be eligible for a place in the Masters of Biotechnology (Biomedical) (Advanced).

Program Learning Outcome
1. Have knowledge and understanding of the content, technologies and practices of biotechnology and how they are translated to applications with a focus on biomedical science.
2. Be able to locate, analyse, evaluate and synthesise biomedical, business and industry and social information from a wide variety of sources in a planned, structured and timely manner.
3. Be able to communicate scientific and technological knowledge across a wide range of cultural contexts, and to effectively communicate within working groups.
4. Be able to evaluate, select and use appropriate contemporary biomedical technologies.
5. Be able to communicate the importance of continuous improvement and learning, and the application of multi-disciplinary approaches in biotechnology.
6. Be able to commit to the highest standards of professional endeavor and the ability to take a leadership role in the global biotechnology community.
7. Be able to discuss the importance of the ethical, social and cultural issues and their importance in the exercise of professional skills and responsibilities in biotechnologies in particular.
8. Be able to communicate an understanding of how biomedical research can result in beneficial outcomes.
Conditions

Condition of Continuing Enrolment:  A student must complete 24 units of coursework before commencing the capstone project.

Interruption of program: Students must apply for permission from the Executive Dean or delegate before taking a Leave of Absence. Any extension of the leave without approval will result in the loss of place in the program but an application may be made to be re-admitted to the program subject to the admission procedures in place at the time.

Program Maximum Duration: As specified in Table 1 of the Coursework Academic Programs Policy, this program must be completed within a Maximum Duration which includes any periods of non-enrolment, leave of absence or approved study at other institutions for credit towards a Program. 

Academic Program Rules for Master of Biotechnology (Biomedical)

There shall be a Master of Biotechnology (Biomedical) .

Qualification Requirements
Academic Program: 

To qualify for the degree of Master of Biotechnology (Biomedical), the student must complete satisfactorily a program of study consisting of the following requirements with a combined total of not less than 48 units, comprising:

  1. Core courses to the value of 15 units
  2. Research equivalent courses to the value of 12 units in the form of a Biotechnology Capstone Project
  3. Elective courses to the value of 21 units